Sienna Biopharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Sep '19 Sep 30, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Net Income	-47.95	-73.47	-50.55	-21.16	-11.29
Depreciation & Amortization	0.15	0.16	0.12	0.07	0.03
Other Amortization	1.13	0.26	0.73	-	-
Loss (Gain) From Sale of Assets	0.02	0	0.01	-	-
Stock-Based Compensation	5.12	4.7	2.11	0.41	0.11
Other Operating Activities	-29.39	3.49	5.05	0.57	1.08
Change in Accounts Payable	-9.14	2.17	2.87	2.85	0.72
Change in Other Net Operating Assets	-5.28	1	-1.35	-0.35	-0.63
Operating Cash Flow	-54.63	-61.69	-41.01	-17.61	-9.98
Capital Expenditures	-0.01	-0.04	-0.27	-0.24	-0.09
Sale of Property, Plant & Equipment	-	-	0.01	-	-
Cash Acquisitions	-	-	-	-6.82	-
Investing Cash Flow	-0.01	-0.04	-0.27	-7.06	-0.09
Short-Term Debt Issued	-	-	3.91	-	13
Long-Term Debt Issued	-	29.87	-	-	-
Total Debt Issued	0.01	29.87	3.91	-	13
Short-Term Debt Repaid	-	-	-	-	-13.89
Total Debt Repaid	-20	-	-	-	-13.89
Net Debt Issued (Repaid)	-19.99	29.87	3.91	-	-0.89
Issuance of Common Stock	22.17	6.09	66.57	0.83	0.19
Repurchase of Common Stock	-	-	-	-	-3.24
Financing Cash Flow	2.17	35.96	106.78	28.84	14.62
Foreign Exchange Rate Adjustments	-0.14	-0.17	-0.05	0.03	-
Net Cash Flow	-52.61	-25.94	65.45	4.2	4.55
Free Cash Flow	-54.64	-61.73	-41.29	-17.85	-10.07
Free Cash Flow Per Share	-2.05	-3.02	-4.24	-10.54	-5.89
Cash Interest Paid	0.98	0.98	-	-	0.16
Levered Free Cash Flow	-36.09	-21.7	-29.35	-3.51	-
Unlevered Free Cash Flow	-36.09	-21.95	-29.62	-3.51	-
Change in Net Working Capital	14.37	-17.1	3.09	-8.12	-

Source: S&P Capital IQ. Standard template. Financial Sources.